Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute

The company has received a patent in the United States for its mucoadhesive patch technology, M045A, developed for the treatment of recurrent aphthous stomatitis (mouth ulcers).

Gradientech has received a Notice of Allowance in the United States for its single-use microfluidic test, a key component of the CE marked QuickMIC system.

The patent covers the use of AC01 for the treatment of heart failure with reduced ejection fraction (HFrEF).

The United States Patent and Trademark Office (USPTO) has granted a patent covering Alligator’s bispecific antibody format.

The new patent secures long term protection for the Salipro platform technologies, extending exclusivity until 2042 and reinforcing the company’s position as a premier partner for drug discovery against challenging drug targets.

The company has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis). The patent approval strengthens the company’s intellectual property portfolio and represents an important milestone ahead of the international PCT […]

The United States Patent and Trademark Office has granted a patent covering the composition of matter of ATOR-4066, the company’s bispecific antibody targeting CD40 and CEACAM5.